Contract Research Organization WCCT Global Announces Completion of 300 Subject Phase I Clinical Trial

Share Article

WCCT Global had recently completed a 300 subject phase I clinical trial.

WCCT Global, a contract research organization with Early Development operations headquartered in Southern California announced the completion of their largest phase I clinical trial since their founding in 2003. Although WCCT has always had a strong focus on conducting large phase I clinical research studies, this is the first study that has required more than 300 participants to be recruited over a 30-Day period. Furthermore, 98% of the participants successfully completed the trial. The WCCT Global, Cypress, CA Clinical Pharmacology Unit is configured specifically to manage large phase I clinical trials. Their Cypress location has 150 beds with 3 separate and distinct confinement wards, enabling WCCT Global to accommodate multiple projects, simultaneously. WCCT Global also has special complementary systems to insure participant recruitment and retention into ongoing clinical research projects. WCCT Global is proud to report an overall subject retention rate of 94.7%.

The WCCT Global ability to screen, enroll and treat large numbers of subjects according to the specific, often complex, demands of a research protocol is only made possible by their highly qualified and dedicated staff members. WCCT Global has a team dedicated to making Phase I research a smooth and successful process. WCCT Global boasts about their ability to screen 55 subjects at their Cypress location on any given day. WCCT Global’s V.P. of Business Development Talia Nikolao stated, “When we are discussing our phase I capabilities with clients, they are stunned by how efficient our phase I unit is from prescreening through study completion.”

Information about WCCT Global:

WCCT Global is a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting-edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.

If you would like to request information about how WCCT Global can assist you with your next clinical study, CLICK HERE.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Talia A. Nikolao, M.B.A.
WCCT Global, LLC
1.714.252.0700 2201
Email >
Follow us on
Visit website